Your browser doesn't support javascript.
loading
SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects.
Zhang, Jiantao; Hom, Kellie; Zhang, Chenyu; Nasr, Mohamed; Gerzanich, Volodymyr; Zhang, Yanjin; Tang, Qiyi; Xue, Fengtian; Simard, J Marc; Zhao, Richard Y.
Affiliation
  • Zhang J; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Hom K; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.
  • Zhang C; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Nasr M; Drug Development and Clinical Sciences Branch, Division of AIDS, NIAID, National Institutes of Health, Bethesda, MD 20892, USA.
  • Gerzanich V; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Zhang Y; Department of Veterinary Medicine, University of Maryland, College Park, MD 20742, USA.
  • Tang Q; Department of Microbiology, Howard University College of Medicine, Washington, DC 20059, USA.
  • Xue F; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.
  • Simard JM; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Zhao RY; Research & Development Service, VA Maryland Health Care System, Baltimore, MD 21201, USA.
Pathogens ; 13(1)2024 Jan 14.
Article in En | MEDLINE | ID: mdl-38251382

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pathogens Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pathogens Year: 2024 Type: Article Affiliation country: United States